• Company
• Reimb pricing negotiations for Luxturna start in KOR
• by Eo, Yun-Ho Oct 23, 2023 05:14am

• Company
• The DPP4i+SGLT2i diabetes combination drug market
• by Kim, Jin-Gu Oct 23, 2023 05:14am

• Policy
• Announcement of dual pricing system
• by Lee, Jeong-Hwan Oct 20, 2023 05:32am

• Company
• LG Chem-BR Pharm signs MOU for HP Vitaran in CHN
• by Lee, Seok-Jun Oct 20, 2023 05:31am

• Company
• Gilead’s TNBC drug Trodelvy is released in KOR
• by Son, Hyung-Min Oct 20, 2023 05:31am

• Opinion
• [Reporter's view]Skill is more important than trends
• by Oct 20, 2023 05:31am

• Policy
• Will a new Alzheimer’s drug be introduced in 20 yrs in KOR?
• by Lee, Tak-Sun Oct 20, 2023 05:31am

• Opinion
• [Reporter's view]Promotion of pharmaceutical & bio-industry
• by Lee, Jeong-Hwan Oct 19, 2023 05:30am

• Company
• War between the U.S. and Russia spreads Middle East risk
• by Kim, Jin-Gu Oct 19, 2023 05:29am

• Policy
• HIRA ‘will discuss reimb obesity treatments with MOHW'
• by Lee, Tak-Sun Oct 19, 2023 05:29am